Evogene
Dr. Nir Arbel was appointed as Chief Product Officer in August, 2021. Dr. Arbel has over ten years of experience in Biotech and MedTech companies in product development and commercialization. Prior to joining Evogene, Dr. Arbel served as CEO and Co-Founder of Carmentix Pte Ltd, Singapore, a company focused on high risk pregnancy prognosis. Prior to that, Dr. Arbel served as the Operating Partner in Esco Ventures, a MedTech fund based in Singapore.
Dr. Arbel holds a Ph.D. in Biochemistry from Ben Gurion University.
This person is not in any teams
This person is not in any offices
Evogene
2 followers
Evogene Ltd. is an Israeli company engaged in research and development for improving crop quality, productivity and economics, through application of plant genomics, for the food, feed and biofuel industries.